This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wong, I. H. N. Articles by Johnson, P. J. Search for Related Content PubMed PubMed Citation Articles by Wong, I. H. N. Articles by Johnson, P. J.

Hematogenous Dissemination of Hepatocytes and Tumor Cells after Surgical Resection of Hepatocellular Carcinoma: A Quantitative Analysis¹

Departments of Anatomical and Cellular Pathology [I. H. N. W.], Surgery [W. Y. L.], and Clinical Oncology [T. L., W. Y., P. J. J.], The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Special Administrative Region

The only hope of long-term survival for patients with hepatocellular carcinoma (HCC) is surgical resection or liver transplantation. However, recurrence or metastasis formation is common after surgery. We aim to assess whether surgical resection leads to hematogenous dissemination of malignant and nontumor hepatocytes and determine the quantity and timing of hepatocyte shedding into the circulation. Using semiquantitative reverse transcription-PCR for -fetoprotein (afp) and albumin (alb) mRNAs, we measured the mass of malignant and nontumor hepatocytes in 53 peripheral blood samples collected preoperatively, intraoperatively, and postoperatively from 13 HCC patients. We compared these data with those in 54 control samples collected from 24 healthy subjects and patients with chronic hepatitis/cirrhosis and 10 hepatocellular adenoma patients who underwent resection. Clinicopathological information of HCC patients was obtained during 3-year follow-up. In 100% (23 of 23) of HCC and adenoma patients, alb mRNA levels increased 10–10⁶-fold intraoperatively and then markedly declined within 8 weeks after operation. Levels of afp mRNA increased 5–7600-fold preoperatively in 8% (1 of 13) and postoperatively in 70% (9 of 13) of HCC patients. All five HCC patients with persistently elevated afp mRNA levels died from intrahepatic/extrahepatic metastasis, liver recurrence, or persistent HCC within 1 year after surgery. The absence/clearance of afp mRNA in 75% (six of eight) of survivors was strongly associated with the absence of metastasis/recurrence (P = 0.02). We present evidence that alb-expressing hepatocytes are released intraoperatively into the circulation, and afp-expressing tumor cells are disseminated mostly postoperatively that may potentially be the source of recurrence or metastasis. Sequential quantification of both alb and afp mRNAs may provide insights for risk assessment and prognostic indication.

This article has been cited by other articles:

				H. S. Park, S. H. Lee, Y. I. Kim, J. S. Lee, M. K. Lim, J.-W. Park, J. H. Lee, and C.-M. Kim Postbiopsy Arterioportal Fistula in Patients with Hepatocellular Carcinoma: Clinical Significance in Transarterial Chemoembolization Am. J. Roentgenol., February 1, 2006; 186(2): 556 - 561. [Abstract] [Full Text] [PDF]

				K.-S. Jeng, I-S. Sheen, and Y.-C. Tsai Circulating Messenger RNA of {alpha}-Fetoprotein: A Possible Risk Factor of Recurrence After Resection of Hepatocellular Carcinoma Arch Surg, October 1, 2004; 139(10): 1055 - 1060. [Abstract] [Full Text] [PDF]

				S. C. H. Yu, D. Y. M. Lo, C. B. Ip, C. T. Liew, T. W. T. Leung, and W. Y. Lau Does Percutaneous Liver Biopsy of Hepatocellular Carcinoma Cause Hematogenous Dissemination? An In Vivo Study with Quantitative Assay of Circulating Tumor DNA Using Methylation-Specific Real-Time Polymerase Chain Reaction Am. J. Roentgenol., August 1, 2004; 183(2): 383 - 385. [Abstract] [Full Text] [PDF]

				I. H.N. Wong The Sporadic Nature of Shedding Cells in Blood: Multiple RNA Diagnostic Testing and Prognostication of Cancer Progression Clin. Chem., September 1, 2003; 49(9): 1429 - 1431. [Full Text] [PDF]

				N. Waguri, T. Suda, M. Nomoto, H. Kawai, Y. Mita, T. Kuroiwa, M. Igarashi, M. Kobayashi, Y. Fukuhara, and Y. Aoyagi Sensitive and Specific Detection of Circulating Cancer Cells in Patients with Hepatocellular Carcinoma; Detection of Human Telomerase Reverse Transcriptase Messenger RNA after Immunomagnetic Separation Clin. Cancer Res., August 1, 2003; 9(8): 3004 - 3011. [Abstract] [Full Text] [PDF]

				I. H. N. Wong, J. Zhang, P. B. S. Lai, W. Y. Lau, and Y. M. Dennis Lo Quantitative Analysis of Tumor-derived Methylated p16INK4a Sequences in Plasma, Serum, and Blood Cells of Hepatocellular Carcinoma Patients Clin. Cancer Res., March 1, 2003; 9(3): 1047 - 1052. [Abstract] [Full Text] [PDF]

				M. Sakon, H. Nagano, S. Nakamori, K. Dono, K. Umeshita, T. Murakami, H. Nakamura, and M. Monden Intrahepatic Recurrences of Hepatocellular Carcinoma After Hepatectomy: Analysis Based on Tumor Hemodynamics Arch Surg, January 1, 2002; 137(1): 94 - 99. [Abstract] [Full Text] [PDF]

				I. H.N. Wong, Y.M. D. Lo, P. B.S. Lai, and P. J. Johnson Relationship of p16 Methylation Status and Serum {alpha}-Fetoprotein Concentration in Hepatocellular Carcinoma Patients Clin. Chem., September 1, 2000; 46(9): 1420 - 1422. [Full Text] [PDF]

				I. H. N. Wong, Y. M. Dennis Lo, W. Yeo, W. Y. Lau, and P. J. Johnson Frequent p15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients Clin. Cancer Res., September 1, 2000; 6(9): 3516 - 3521. [Abstract] [Full Text]

				I. H. N. Wong, A. T. Chan, and P. J. Johnson Quantitative Analysis of Circulating Tumor Cells in Peripheral Blood of Osteosarcoma Patients Using Osteoblast-specific Messenger RNA Markers: A Pilot Study Clin. Cancer Res., June 1, 2000; 6(6): 2183 - 2188. [Abstract] [Full Text]